Microfabrica Partners with US Endoscopy

SANTA CLARA, CA – Microfabrica partners with US Endoscopy to produce the world's first submillimeter biopsy forceps, designed to improve the reliability of tissue biopsy in the GI tract including biopsy of pancreatic cystic lesions. Pancreatic cancer is the fourth leading cause of cancer-related deaths in the US, estimated to surpass breast cancer in 2017.

Like 3D Printing, Microfabrica can produce complex three dimensional structures, with moving parts, in layers, directly from a digital model. Unlike 3D Printing, Microfabrica leverages the semiconductor manufacturing paradigm, enabling them to produce high precision, micro scale metal devices in commercial volumes. These structures require no assembly and the entirety of the mechanism is monolithically fabricated by Microfabrica.

For more information, visit:
http://www.microfabrica.com
http://www.usendoscopy.com

Suggested Articles

Tech companies unable to generate cash will likely be out of business, clearing the market, says Siebel systems founder

Intel diversified and saw growth in 2019, unlike competitors focused heavily on memory

Technology efforts being made on a number of fronts to battle COVID-19 highlight the news for the week of March 30.